Clene Inc.

Consumer Staples · Packaged Foods · United States

Last price 3.9 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 55.43M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company’s lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinde...